The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Version 2 2024-06-06, 08:19
Version 1 2021-11-12, 08:08
journal contribution
posted on 2022-01-01, 00:00 authored by S R Susai, D Mongan, C Healy, M Cannon, B Nelson, C Markulev, M R Schäfer, M Berger, N Mossaheb, M Schlögelhofer, S Smesny, I B Hickie, G E Berger, E Y H Chen, L de Haan, D H Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, Alison YungAlison Yung, P D McGorry, M Föcking, D Cotter, G P AmmingerThe association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
History
Journal
Brain, Behavior, and ImmunityVolume
99Pagination
147 - 156Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
Link to full text
ISSN
0889-1591eISSN
1090-2139Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
Keywords
Biological markerCYTOKINE ALTERATIONSDEPRESSION-LIKE BEHAVIORSDOSE-RESPONSEImmune markers and clinically high-riskImmunologyLife Sciences & Biomedicinen-3 poly unsaturated fatty acidNeurosciencesNeurosciences & NeurologyOmega 3 fatty acidOMEGA-3P40 HOMODIMERPOLYUNSATURATED FATTY-ACIDSPsychiatryRANDOMIZED CONTROLLED-TRIALSCHIZOPHRENIAScience & TechnologySUPPLEMENTATION LOWERS INFLAMMATIONULTRA-HIGH RISKImmunology
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC